Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 197

1.

Immunogenicity of a 23-valent pneumococcal polysaccharide vaccine among Mexican children.

Espinosa-Padilla SE, Murata C, Estrada-Parra S, Santos-Argumedo L, Mascareñas C, Franco-Paredes C, Espinosa-Rosales FJ.

Arch Med Res. 2012 Jul;43(5):402-5. doi: 10.1016/j.arcmed.2012.07.005. Epub 2012 Aug 3.

PMID:
22868187
2.
3.

The immunogenicity and safety of pneumococcal conjugate vaccine in human immunodeficiency virus-infected Thai children.

Thanee C, Pancharoen C, Likitnukul S, Luangwedchakarn V, Umrod P, Phasomsap C, Apornpong T, Chuanchareon T, Butterworth O, Puthanakit T.

Vaccine. 2011 Aug 11;29(35):5886-91. doi: 10.1016/j.vaccine.2011.06.072. Epub 2011 Jul 3. Erratum in: Vaccine. 2011 Oct 26;29(46):8470.

PMID:
21729732
4.

Immunogenicity and safety of a pneumococcal conjugate 7-valent vaccine in infants with sickle cell disease.

Reinert P, Benkerrou M, de Montalembert M, Lesprit E, Abadie I, Bernaudin F, Doit C, Bingen E, Tetelboum R, Bonnet E.

Pediatr Infect Dis J. 2007 Dec;26(12):1105-9.

PMID:
18043446
5.

Deficient IgA and IgG2 anti-pneumococcal antibody levels and response to vaccination in otitis prone children.

Dhooge IJ, van Kempen MJ, Sanders LA, Rijkers GT.

Int J Pediatr Otorhinolaryngol. 2002 Jun 17;64(2):133-41.

PMID:
12049826
6.

Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine administered to older infants and children naïve to pneumococcal vaccination.

Wysocki J, Brzostek J, Szymański H, Tetiurka B, Toporowska-Kowalska E, Wasowska-Królikowska K, Sarkozy DA, Giardina PC, Gruber WC, Emini EA, Scott DA.

Vaccine. 2015 Mar 30;33(14):1719-25. doi: 10.1016/j.vaccine.2015.02.005. Epub 2015 Feb 17.

PMID:
25698485
7.

Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine in healthy infants in Japan.

Togashi T, Yamaji M, Thompson A, Giardina PC, Aizawa M, Patterson S, Gruber WC, Scott DA; 3003 Study Group..

Pediatr Infect Dis J. 2013 Sep;32(9):984-9. doi: 10.1097/INF.0b013e318293007e.

PMID:
23538524
8.

Pneumococcal conjugate vaccine primes for polysaccharide-inducible IgG2 antibody response in children with recurrent otitis media acuta.

Breukels MA, Rijkers GT, Voorhorst-Ogink MM, Zegers BJ, Sanders LA.

J Infect Dis. 1999 May;179(5):1152-6.

PMID:
10191217
9.

Evaluation of humoral response to heptavalent pneumococcal conjugate vaccine in HIV-infected children.

Costa Ide C, Guilardi F, Kmiliauskis MA, Arslanian C, Baldacci ER.

Rev Saude Publica. 2008 Oct;42(5):844-50. Epub 2008 Aug 28. English, Portuguese.

10.

Immunogenicity and safety of 13-valent pneumococcal conjugate vaccine in children previously immunized with 7-valent pneumococcal conjugate vaccine.

Frenck R Jr, Thompson A, Yeh SH, London A, Sidhu MS, Patterson S, Gruber WC, Emini EA, Scott DA, Gurtman A; 3011 Study Group..

Pediatr Infect Dis J. 2011 Dec;30(12):1086-91. doi: 10.1097/INF.0b013e3182372c6a.

PMID:
21983216
11.

Immunogenicity, reactogenicity and safety of the 10-valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in Mexican infants.

Ruiz-Palacios GM, Guerrero ML, Hernández-Delgado L, Lavalle-Villalobos A, Casas-Muñoz A, Cervantes-Apolinar Y, Moreira M, Schuerman L.

Hum Vaccin. 2011 Nov;7(11):1137-45. doi: 10.4161/hv.7.11.17984. Epub 2011 Nov 1.

PMID:
22048109
12.

Immunologic priming of young children by pneumococcal glycoprotein conjugate, but not polysaccharide, vaccines.

O'Brien KL, Steinhoff MC, Edwards K, Keyserling H, Thoms ML, Madore D.

Pediatr Infect Dis J. 1996 May;15(5):425-30.

PMID:
8724065
13.

Avidity and subclasses of IgG after immunization of infants with an 11-valent pneumococcal conjugate vaccine with or without aluminum adjuvant.

Wuorimaa T, Dagan R, Väkeväinen M, Bailleux F, Haikala R, Yaich M, Eskola J, Käyhty H.

J Infect Dis. 2001 Nov 1;184(9):1211-5. Epub 2001 Sep 25.

PMID:
11598848
14.

Phase 3 trial evaluating the immunogenicity, safety, and tolerability of manufacturing scale 13-valent pneumococcal conjugate vaccine.

Gadzinowski J, Albrecht P, Hasiec B, Konior R, Dziduch J, Witor A, Mellelieu T, Tansey SP, Jones T, Sarkozy D, Emini EA, Gruber WC, Scott DA.

Vaccine. 2011 Apr 5;29(16):2947-55. doi: 10.1016/j.vaccine.2011.02.002. Epub 2011 Feb 16.

PMID:
21335032
15.

Immunogenicity and safety of heptavalent conjugate vaccine against Streptococcus pneumoniae in pre-term Polish infants.

Szynczewska E, Chlebna-Sokół D.

Vaccine. 2011 Sep 16;29(40):7107-13. doi: 10.1016/j.vaccine.2011.06.124. Epub 2011 Jul 29.

PMID:
21803093
16.

[Experience of application of pneumococcus vaccines for studies of humoral immunity].

Iastrebova NE, Grishchenko NV, Kostinov MP, Salkina OA, Snegova NV, Vaneeva NP.

Zh Mikrobiol Epidemiol Immunobiol. 2013 Mar-Apr;(2):96-101. Russian.

PMID:
23805679
17.

Response to a heptavalent conjugate Streptococcus pneumoniae vaccine in children with recurrent infections who are unresponsive to the polysaccharide vaccine.

Sorensen RU, Leiva LE, Giangrosso PA, Butler B, Javier FC 3rd, Sacerdote DM, Bradford N, Moore C.

Pediatr Infect Dis J. 1998 Aug;17(8):685-91.

PMID:
9726341
18.

Immunogenicity of a 23-valent pneumococcal polysaccharide vaccine in elderly residents of a long-term care facility.

Valenzuela MT, Altuzarra RH, Trucco OA, Villegas RR, Inostroza JS, Granata PS, Fleiderman JV, Maggi LC.

Braz J Infect Dis. 2007 Jun;11(3):322-6.

19.

Safety and immunogenicity of a 13-valent pneumococcal conjugate vaccine compared to those of a 7-valent pneumococcal conjugate vaccine given as a three-dose series with routine vaccines in healthy infants and toddlers.

Esposito S, Tansey S, Thompson A, Razmpour A, Liang J, Jones TR, Ferrera G, Maida A, Bona G, Sabatini C, Pugni L, Emini EA, Gruber WC, Scott DA, Principi N.

Clin Vaccine Immunol. 2010 Jun;17(6):1017-26. doi: 10.1128/CVI.00062-10. Epub 2010 Apr 28.

20.

[Effect of vaccination against pneumococcal infection in children with type 1 diabetes mellitus].

Tarasova AA, Kostinov MP, Iastrebova NE, Skochilova TV.

Zh Mikrobiol Epidemiol Immunobiol. 2007 Nov-Dec;(6):45-9. Russian.

PMID:
18277539

Supplemental Content

Support Center